IMMUNITYBIO INC. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of Directors: Patrick Soon-Shiong, M.D.

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Patrick Soon-Shiong, M.D.”): 556,206,355 for, 6,438,677 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 1,149,584 for, 2,017,041 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Cheryl L. Cohen

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 561,728,022 for, 917,010 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 3,001,607 for, 165,018 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Richard Adcock

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Richard Adcock”): 561,327,002 for, 1,318,030 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 3,002,550 for, 164,075 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Michael D. Blaszyk

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Michael D. Blaszyk”): 561,317,164 for, 1,327,868 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 2,767,813 for, 398,812 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: John Owen Brennan

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: John Owen Brennan”): 560,173,170 for, 2,471,862 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 2,998,303 for, 168,322 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Wesley Clark

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Wesley Clark”): 560,587,816 for, 2,057,216 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 3,001,607 for, 165,018 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Linda Maxwell

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Linda Maxwell, M.D.”): 561,368,993 for, 1,276,039 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 2,767,813 for, 398,812 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Christobel Selecky

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Christobel Selecky”): 561,329,841 for, 1,315,191 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 2,767,813 for, 398,812 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Barry J. Simon, M.D.

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Barry J. Simon, M.D.”): 559,237,600 for, 3,407,432 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2025 annual meeting of stockholders based on the following results of voting.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 1,794,694 for, 1,371,931 withheld.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: To approve an amendment to the ImmunityBio, Inc. 2015 Equity Incentive Plan to increase the number of shares of the company's common stock authorized for issuance under the plan by 19,900,000 shares.

IMMUNITYBIO INC.’s own tally for this item (“2. Approval of Amendment to Increase the Number of Shares of Common Stock Authorized for Issuance under the ImmunityBio, Inc”): 547,258,257 for, 12,472,068 against — passed, per its Form 8-K filed June 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The amendment to increase the number of shares of Common Stock authorized for issuance under the company's 2015 Equity Incentive Plan by 19,900,000 shares was approved by our stockholders based on the following results of voting:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 328,826 for, 2,837,799 against.

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

Description as filed by funds: To approve, on an advisory (non-binding) basis, the compensation of our Named Executive Officers ("Say-on-Pay").

IMMUNITYBIO INC.’s own tally for this item (“3. Advisory Vote to Approve Named Executive Officer Compensation, or Say-on-Pay”): 556,683,366 for, 2,530,858 against — passed, per its Form 8-K filed June 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “On an advisory, non-binding basis, the compensation of our named executive officers for the year ended December 31, 2023, as disclosed in our proxy statement filed with the Securities and Exchange Commission on April 29, 2024, was approved by our stockholders based on the following results of votin…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 49 managers: 3,149,932 for, 16,693 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 129 managers: 9,280,552 for, 81,784 against, 1,000 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the selection of Ernst & Young LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2024.

IMMUNITYBIO INC.’s own tally for this item (“4. Ratification of Appointment of Independent Registered Public Accounting Firm”): 606,920,437 for, 2,216,896 against — passed, per its Form 8-K filed June 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified by our stockholders based on the following results of voting:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 3,089,114 for, 77,511 against.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.